Insider Transactions in Q4 2021 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,418
-85.11%
|
$340,320
$240.0 P/Share
|
|
Dec 27
2021
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,418
+36.81%
|
$1,418
$1.51 P/Share
|
|
Dec 23
2021
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,342
-97.11%
|
$2,002,080
$240.0 P/Share
|
|
Dec 23
2021
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,342
+43.45%
|
$8,342
$1.51 P/Share
|
|
Dec 07
2021
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
25,106
-19.89%
|
$5,397,790
$215.0 P/Share
|
|
Nov 20
2021
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Direct |
8,420
+4.48%
|
-
|
|
Nov 20
2021
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
8,420
-87.26%
|
-
|
|
Nov 06
2021
|
Marilyn C Nelson Director |
SELL
Bona fide gift
|
Indirect |
11,781
-8.54%
|
-
|
|
Oct 15
2021
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+36.33%
|
$0
$0.94 P/Share
|
|
Oct 08
2021
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+2.7%
|
$23,100
$231.04 P/Share
|
|
Oct 08
2021
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+0.33%
|
$14,784
$231.04 P/Share
|
|
Oct 08
2021
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+3.24%
|
$14,784
$231.04 P/Share
|
|
Oct 08
2021
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$13,629
$231.04 P/Share
|
|
Oct 08
2021
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+19.93%
|
$12,936
$231.04 P/Share
|